CLINTABS^® (clindamycin hydrochloride) Tablets

CLINTABS^® (clindamycin hydrochloride) Tablets contain clindamycin hydrochloride which is the hydrated salt of clindamycin. Clindamycin is a semisynthetic antibiotic produced by a 7(S)-chlorosubstitution of the 7(R)-hydroxyl group of a naturally produced antibiotic produced by Streptomyces lincolnensis var. lincolnensis.  Approved for use in dogs.

SEE PRODUCT INSERT FOR COMPLETE PRODUCT INFORMATION

Indications:  CLINTABS^® Tablets (brand of clindamycin hydrochloride) (for use in dogs only) are indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below:

Skin Infections (wounds and abscesses) due to coagulase positive staphylococci (Staphylococcus aureus or Staphylococcus intermedius).

Deep wounds and abscesses due to Bacteroides fragilis, Prevotella melaninogenicus, Fusobacterium necrophorum and Clostridium perfringens.

Dental infections due to Staphylococcus aureus, Bacteroides fragilis, Prevotella melaninogenicus, Fusobacterium necrophorum and Clostridium perfringens.

Osteomyelitis due to Staphylococcus aureus, Bacteroides fragilis, Prevotella melaninogenicus, Fusobacterium necrophorum and Clostridium perfringens.

For full dosing information, please refer to the package insert.

For Veterinary Professionals:

We have a separate website specifically tailored to veterinary professionals with more in depth information on all of our products. Click here to view this product's page on our vet website!

Download the Product Insert

IMPORTANT SAFETY INFORMATION:
CLINTABS^® Tablets are contraindicated in animals with a history of hypersensitivity to clindamycin or lincomycin. Do not use in rabbits, hamsters, guinea pigs, horses, chinchillas or ruminating animals.  Keep out of reach of children. Not for human use. Use with caution in patients with very severe kidney or liver disease and in animals receiving neuromuscular blocking agents such as succinylcholine.  Safety in pregnant females or breeding males has not been established. Treatment of acute infections should not be continued for more than three or four days if no response to therapy is seen. Monitor blood work in animals on either high dose or prolonged therapy. Side effects occasionally observed include vomiting and diarrhea. For complete product information refer to the product insert.

Safety Data Sheet (SDS) Request